Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.05 (8.333%)
Open: 0.625
High: 0.625
Low: 0.625
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Rio Tinto Up On Plan To Return Sale Proceeds

Thu, 20th Sep 2018 10:30

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rio Tinto, up 1.9%. The miner intends to return its coal disposal proceeds to shareholders through a USD3.2 billion share buyback programme. The programme will combine an off-market buyback tender targeting up to 41.2 million shares, of around USD1.9 billion, and on-market purchases. Details of the on-market purchases will be set out following the completion of the off-market buyback, which is expected on November 12. The disposal proceeds come from the completed sales of Hail Creek, Valeria and Kestrel, all located in Australia.----------ITV, up 0.4%. Panmure upgraded the media company to a Buy rating from Hold.----------FTSE 100 - LOSERS----------Kingfisher, down 0.7%. The home improvement and garden centres retailer recovered from closing down 6.3% on Wednesday, as a result of a profit drop. For the six months to July 31, Kingfisher posted pretax profit down 30% to GBP281 million from GBP402 million a year ago. On an adjusted basis, pretax profit also fell, by 18% to GBP323 million. Meanwhile, revenue increased 1.2% to GBP6.08 billion compared to GBP6.01 billion a year prior.----------FTSE 250 - WINNERS----------AVEVA Group, up 3.7%. Barclays upgraded the industrial software firm to an Overweight rating from Equal Weight, and also raised the target price to 3,150 pence from 2,800p. AVEVA shares are currently trading at 2,950p. ----------Kier Group, up 4.8%. The infrastructure services swung to a pretax profit of GBP106.2 million in the year to the end of June, swinging from a loss of GBP14.2 million a year earlier as revenue improved by 5% to GBP4.5 billion from GBP4.3 billion. This was due to substantially reduced one off costs to GBP30.7 million from GBP140.3 million the prior year, when the group conducted a portfolio simplification, involving the closure of its Hong Kong and Caribbean operations. On an adjusted basis, pretax profit rose by 9.0% to GBP136.9 million from GBP126.1 million the prior year.----------Weir Group, up 3.0%. Morgan Stanley upgraded the engineering company to an Overweight rating from Equal-Weight, but lowered its price target to 2,120 pence from 2,240p. Weir shares are currently trading at 1,797.0p.----------Inmarsat, up 2.5%. The satellite communications provider agreed a strategic collaboration with Panasonic Avionics Corp to offer broadband in-flight connectivity to the commercial aviation industry, over an initial ten-year period. Under the terms of the agreement, Inmarsat will become Panasonic's exclusive provider of Ka-band in-flight connectivity for commercial aviation, enabling the company to offer high-speed connectivity.----------FTSE 250 - LOSERS----------IG Group Holdings, down 8.8%. The online trading platform provider said revenue in the three months to the end of August declined by 5% to GBP128.9 million on weak performance in the UK and Europe, the Middle East & Africa regions, where revenue fell by 8% and 12%, respectively. The result was hit by a reduction in client numbers. In the UK, the number of clients fell by 13% to 34,000, while the Europe, the Middle East & Africa saw a 10% decrease in client numbers to 27,200.----------OTHER MAIN MARKET AND AIM - WINNERS----------Adept4, up 34%. The IT as a Service provider said it as settled its legal dispute with the vendors of Adept4 Managed IT Ltd, with the verdict being that Adept4 will not pay the deferred payment of GBP1.0 million or the contingent payment of GBP1.5 million to the vendors. In fact, the vendors will pay a cash sum to Adept4 in November, which is expected to result in a small cash flow to the company.----------Lansdowne Oil & Gas, up 18%. The oil and gas company said it has signed a binding farm-out agreement with APEC Energy Enterprises Ltd over the Barryoe oil accumulation, offshore Ireland, With an enhanced multi-well drilling programme of five firm wells and two option wells, preparation work is expected to start immediately, with first drilling expected in the second quarter of 2019. ----------Crimson Tide, up 38%. The company, which provides a workforce management software application called mpro5, signed its first subscription agreements in the Middle East with two clients. "Both companies will be completing maintenance, engineering, and health & safety workflows on mpro5 and the company is hopeful of more wins to come," Crimson said. Furthermore, it announced a contract win with an unnamed USD20 billion US pharma company to provide a patient portal for an anti-cholesterol drug.----------OTHER MAIN MARKET AND AIM - LOSERS----------N4 Pharma, down 38%. The pharmaceutical company, following a strategic review made the decision to close its Genetics division, following a full data report of the clinical trial for the sildenafil reformulation, identifiying that the risk reward profile in reformulate the drug would be too great. As a result, N4 Pharma will focus all its efforts on its Vaccine division, particularly the product Nuvec.----------Minoan Group, down 23%. The travel agency has continued to implement its cost reduction programme, the latest step being the agreement to sell its travel & leisure unit Stewart Travel Ltd to its primary lender Zachary Asset Holdings Ltd for GBP6.6 million in order to reduce debt. However, the group will still need additional funds to pay back its debt to Zachary, which is expected to be GBP900,000 once the sale is completed.----------Petro Matad, down 22%. The Mongolian oil explorer said it has drilling the Snow Leopard-1 well to a total depth of 2,930 metres, however the deeper objective of the well revealed no oil or gas shows, with subsequent logging showing the sediments to be water bearing instead. The Snow-Leopard-1 well will be plugged and abandoned, and the rig used will be moved to the Wild Horse 1 location, which is target 480 million barrels of oil.----------
More News
15 Jul 2022 13:23

N4 Pharma upbeat on latest tumour suppression study data

(Sharecast News) - Specialist pharmaceutical developer N4 Pharma updated the market on its recent preclinical study with TNF alpha on Friday.

Read more
15 Jul 2022 11:21

AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
17 Mar 2022 16:28

UK shareholder meetings calendar - next 7 days

Friday 18 March  
Caracal Gold PLCAGM
Chenavari Toro Income Fund LtdAGM
Monday 21 March 
Aferian PLCAGM
Altona Rare Earths PLCAGM
Helical PLCGM re becoming REIT & buyback
Inland Homes PLCAGM
Tuesday 22 March 
Crest Nicholson Holdings PLCAGM
Hochschild Mining PLCEGM re Amarillo Gold acquisition
Hydro Hotel Eastbourne PLCAGM
Starvest PLCAGM
Sureserve Group plcAGM
Wynnstay Group PLCAGM
Wednesday 23 March 
CML Microsystems PLCGM re employee share plans
Quartix Technologies PLCAGM
Strategic Equity Capital PLCGM re: tender offer
Thursday 24 March 
BlackRock Throgmorton Trust PLCAGM
Independent Investment Trust PLCAGM
N4 Pharma PLCAGM
React Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
23 Feb 2022 14:54

IN BRIEF: N4 Pharma falls as loss widens and Nuvec tests inconclusive

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company - Reports a pretax loss of GBP1.8 million for 2021, widening 18% from GBP1.6 million the previous year. Says year focused on in vivo studies of Nuvec, a delivery system for cancer treatments and vaccines, which did not return any "meaningful" immunological response in studies carried out by Hamburg-based drug development company Evotec SE. Says that on the back of increased data the company can now narrow its focus on the oncology and gene therapy market.

Read more
31 Jan 2022 22:06

TRADING UPDATES: Hiro plans acquisition vehicle IPO; Aquila reviews

TRADING UPDATES: Hiro plans acquisition vehicle IPO; Aquila reviews

Read more
25 Jan 2022 19:12

TRADING UPDATES: Cordiant raises GBP200 million; Home REIT spends

TRADING UPDATES: Cordiant raises GBP200 million; Home REIT spends

Read more
25 Jan 2022 14:50

N4 Pharma outlines work plan after 'encouraging' data

(Sharecast News) - Specialist treatment and vaccine delivery system developer N4 Pharma updated the market on its work plan on Tuesday, following "encouraging data" from its oncology research as announced on 13 December.

Read more
13 Dec 2021 21:57

IN BRIEF: N4 Pharma to focus resources on gene therapy

IN BRIEF: N4 Pharma to focus resources on gene therapy

Read more
13 Dec 2021 14:56

N4 upbeat on cancer treatment progress, vaccine disappoints

(Sharecast News) - Cancer treatment and vaccine delivery system developer N4 Pharma updated the market on data from its proof-of-concept programmes and ongoing activities on Monday.

Read more
1 Nov 2021 06:57

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

Read more
1 Oct 2021 09:35

N4 Pharma granted Europe patent with China equivalent on its way

(Sharecast News) - Specialist pharmaceutical company N4 Pharma announced on Friday that it has been granted a patent for its 'Nuvec' cancer treatment and vaccine delivery system by the European Patent Office (EPO), specifically around its composition, particulate materials, and methods for making the particulate materials.

Read more
1 Oct 2021 08:50

N4 Pharma secures patent in Europe for Nuvec, expects China to follow

N4 Pharma secures patent in Europe for Nuvec, expects China to follow

Read more
20 Sep 2021 12:02

TRADING UPDATES: Christie Group and Open Orphan swing to profit

TRADING UPDATES: Christie Group and Open Orphan swing to profit

Read more
14 Sep 2021 14:31

TRADING UPDATES: Boku launches in Germany; Focusrite trading well

TRADING UPDATES: Boku launches in Germany; Focusrite trading well

Read more
24 Aug 2021 12:35

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.